肝癌早诊新指标有些以偏概全

To query the value of GOLPDH2 as a new marker for early diagnosis of hepatocellular carcinoma

肝癌的早期诊断非常网难。甲胎蛋白(AFP)为肝癌早期诊断的重要血清学指标。但临床上仍有10%～30%肝癌患者的AFP检测呈阴性。是否还有敏感性和特异性更高的肝癌血清诊断标志物呢?本文针对发表在《肝脏病学杂志》(Hepatology)2009年第49卷的一篇文章,就高尔基体磷酸蛋白2作为肝癌血清学诊断指标的研究进行了分析和进一步深入研究,期望在寻找肝癌早诊新标志物方面对大家有所启发和帮助。

The early diagnosis of live cancer is very difficult. Alpha-fetoprotein （AFP） is a clinically important serological indicators for early screening liver cancer. However, there are still 10%-30% liver cancer patients with their AFP test being negative. Is there a serum marker of higher sensitivity and specificity for diagnosing liver cancer？ This paper focuses on the value of serum Golgi Phosphoprotein 2 （GOLPDH2） in early diagnosis of hepatocellular carcinoma （HCC）, which is published in the ＂Hepatology＂, 49th volume in 2009. It is anticipated that our article will give researchers some inspiration and help in screening the new biomarker of HCC early diagnosis.